Literature DB >> 18321362

The prevalence of ESBL-producing E. coli and Klebsiella strains in the Copenhagen area of Denmark.

Anne Kjerulf1, Dennis S Hansen, Dorthe Sandvang, Frank Hansen, Niels Frimodt-Møller.   

Abstract

The main purpose of the study was to investigate the frequency of ESBL-producing E. coli and Klebsiella strains in the Greater Copenhagen area. Four collections of strains were investigated: A) 380 consecutive E. coli and Klebsiella isolates primarily from urine, B) 200 gentamicin-resistant E. coli and Klebsiella isolates primarily from urine, C) 210 consecutive E. coli isolates from blood cultures, and D) 68 cefuroxime-resistant E. coli and Klebsiella isolates primarily from urine. Only one strain per patient was included. Strains with a zone diameter for cefpodoxime <or=23 mm were tested by a phenotypic confirmatory test for ESBL production and all screening test-positive strains were examined with PCR and nucleotide sequencing in order to detect the following ESBL genes: ctx-m, shv, tem and oxa. Strains resistant to cefoxitin were further examined with cefotetan+/-boronic acid in order to detect AmpC. An ESBL gene was detected in 3/3 confirmatory test-positive isolates from collection A, in 14/17 from collection B, and in 41/48 from collection D. The distribution of isolates with the ESBL and/or AmpC enzymes was as follows: CTX-M (n=41), SHV (n=14), AmpC (n=9), CTX-M and AmpC (n=2), SHV and AmpC (n=1). In conclusion, the frequency of ESBL-producing E. coli and Klebsiella isolates was low in the Copenhagen area of Denmark (0.8 %). The most common ESBL genes found in our study were ctx-m and shv genes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18321362     DOI: 10.1111/j.1600-0463.2008.00777.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  6 in total

1.  In vitro activity of beta-lactam antibiotics against CTX-M-producing Escherichia coli.

Authors:  M Tärnberg; A Ostholm-Balkhed; H-J Monstein; A Hällgren; H Hanberger; L E Nilsson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-02-06       Impact factor: 3.267

2.  Evaluation of MLVA for epidemiological typing and outbreak detection of ESBL-producing Escherichia coli in Sweden.

Authors:  Lisa Helldal; Nahid Karami; Christina Welinder-Olsson; Edward R B Moore; Christina Åhren
Journal:  BMC Microbiol       Date:  2017-01-06       Impact factor: 3.605

3.  Antibiotic resistance pattern and molecular characterization of extended-spectrum β-lactamase producing enteroaggregative Escherichia coli isolates in children from southwest Iran.

Authors:  Mansour Amin; Mehrandokht Sirous; Hazhir Javaherizadeh; Mohammad Motamedifar; Morteza Saki; Hojat Veisi; Saeedeh Ebrahimi; Sakineh Seyed-Mohammadi; Mohammad Hashemzadeh
Journal:  Infect Drug Resist       Date:  2018-08-08       Impact factor: 4.003

4.  Prevalence of Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae Causing Bloodstream Infections in Cancer Patients from Southwest of Iran.

Authors:  Effat Abbasi Montazeri; Azar Dokht Khosravi; Morteza Saki; Mehrandokht Sirous; Bijan Keikhaei; Sakineh Seyed-Mohammadi
Journal:  Infect Drug Resist       Date:  2020-05-06       Impact factor: 4.003

5.  Preliminary survey of extended-spectrum β-lactamases (ESBLs) in nosocomial uropathogen Klebsiella pneumoniae in north-central Iran.

Authors:  Sajjad Yazdansetad; Miaad K Alkhudhairy; Reza Najafpour; Elika Farajtabrizi; Reham M Al-Mosawi; Morteza Saki; Elham Jafarzadeh; Farokh Izadpour; Atefeh Ameri
Journal:  Heliyon       Date:  2019-09-17

6.  Transfer of antimicrobial resistance plasmids from Klebsiella pneumoniae to Escherichia coli in the mouse intestine.

Authors:  Susanne Schjørring; Carsten Struve; Karen A Krogfelt
Journal:  J Antimicrob Chemother       Date:  2008-08-13       Impact factor: 5.790

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.